Form4insider filings, from the source

SEC Form 4 · accession 0000874015-17-000012

IONIS PHARMACEUTICALS INC · IONS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
B Lynne Parshall
Officer — COO · Director
Period of report
Jan 15, 2017
Accepted (ET)
Jan 18, 2017 · 6:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 15, 2017M2,595$0.00A19,459D
Common StockF2Jan 17, 2017S965$46.2902D18,494D
Common StockF3Jan 15, 2017M3,437$0.00A21,931D
Common StockF4Jan 17, 2017S1,509$46.2895D20,422D
Common StockF5Jan 15, 2017M5,519$0.00A25,941D
Common StockF6Jan 17, 2017S2,696$46.2895D23,245D
Common StockF7Jan 15, 2017M4,482$0.00A27,727D
Common StockF8Jan 17, 2017S2,076$46.2893D25,651D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF9,F10—Jan 15, 2017A19,606A——Common Stock19,60619,606D
Restricted Stock UnitsF2,F9,F11—Jan 15, 2017M2,595D——Common Stock2,5950D
Restricted Stock UnitsF4,F9,F11—Jan 15, 2017M3,437D——Common Stock3,4373,437D
Restricted Stock UnitsF6,F9,F11—Jan 15, 2017M5,519D——Common Stock5,51911,038D
Restricted Stock UnitsF8,F9,F11—Jan 15, 2017M4,482D——Common Stock4,48213,443D

Explanation of responses